Furthermore, the long-term improvement of depressive symptoms in the patients was significantly correlated with the change of IL-2 levels, in supporting of the pathological role of IL-2 in the development and TMS treatment of depression. The gene discussed is IL2; the disease is depressive symptom measurement.